Journal articleSci Rep2019

9-ING-41, a small molecule inhibitor of GSK-3beta, potentiates the effects of anticancer therapeutics in bladder cancer.

DOI 10.1038/s41598-019-56461-4 ↗ Europe PMC, retrieved 5 November 2026

Journal: Sci Rep
Published: 27 December 2019
Citations: 50
License: cc by

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Trials 1

Its registry lists this paper as results9-ING-41 in Patients With Advanced Cancers NCT03678883 ↗

The registry lists these as results papers; in a hand check of 27 such links about 78% reported the trial’s results, so read the paper before treating it as the outcome.